Home › Funds › PFM Health Sciences, LP › THC

PFM Health Sciences, LP position in THC

TENET HEALTHCARE CORP · Health Care

PFM Health Sciences, LP reported holding 126,572 shares of THC (TENET HEALTHCARE CORP) in its Q2 2026 13F filing — a position valued at US$23.7M, representing 2.07% of its reported portfolio and ranking #12 among its reported holdings. PFM Health Sciences, LP has disclosed THC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)126.57K sh
Reported value held$23.68M
Portfolio Weight2.07%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's THC position evolved

PFM Health Sciences, LP first disclosed a stake in THC in Q3 2023 at 578,704 shares (US$38.1M). The position peaked in Q3 2024 at 589,409 shares, worth US$98.0M. Across 12 filings, PFM Health Sciences, LP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 126,572 shares valued at US$23.7M — a reduction of -271,995 shares quarter over quarter.. Notable position changes include a 68% trim in Q2 2026 (shares rose 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 578.70K $38.13M New
Q4 2023 589.41K $44.54M Add
Q1 2024 589.41K $61.95M Hold
Q2 2024 589.41K $78.41M Hold
Q3 2024 589.41K $97.96M Hold
Q4 2024 491.33K $62.02M Reduce
Q1 2025 491.33K $66.08M Hold
Q2 2025 499.24K $87.87M Add
Q3 2025 461.65K $93.73M Reduce
Q4 2025 397.77K $79.04M Reduce
Q1 2026 398.57K $75.21M Hold
Q2 2026 126.57K $23.68M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About THC and 13F data

THC (TENET HEALTHCARE CORP) is a Health Care company. 40 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$829.1M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$168.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding THC

All THC fund holders →

FAQ

How long has PFM Health Sciences, LP held THC?

PFM Health Sciences, LP has disclosed THC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is PFM Health Sciences, LP's current position in THC?

As of Q2 2026, PFM Health Sciences, LP holds 126.57K shares of THC (TENET HEALTHCARE CORP), valued at $23.68M, representing 2.07% of its reported portfolio and ranking #12.

Has PFM Health Sciences, LP been buying or selling THC?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in THC. The position peaked in Q3 2024 at 589.41K shares.

Which other funds hold THC?

Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.